Triton Therapeutics, Inc.
Stamford, US · Founded 2025 · 2 known investors
Triton Therapeutics is a clinical-stage biotechnology company developing first-in-class medicines for autoimmune and fibrotic diseases.
Founders & leadership
Board
AM
Annie MitsakBoard director
TS
Timothy ShannonBoard director
EG
Elena GrigoryevaBoard director
PF
Paul FonteyneBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$36.4M disclosed across 1 round · 2025
▶$36.4MraisedOct 2025 · 4 investors · PharmaceuticalsRule 506(b)
▶$36.4MraisedOct 2025 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Annie MitsakDirector
- Timothy ShannonDirector
- Elena GrigoryevaDirector
- Paul FonteyneExecutive Officer, Director
- Offering amount
- $36.4M
- Amount sold
- $36.4M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Triton Therapeutics, Inc. do?
- Triton Therapeutics is a clinical-stage biotechnology company developing first-in-class medicines for autoimmune and fibrotic diseases.
- Who are Triton Therapeutics, Inc.'s investors?
- Triton Therapeutics, Inc.'s investors include Canaan Partners, Cure Ventures.
- How much funding has Triton Therapeutics, Inc. raised?
- Triton Therapeutics, Inc. has disclosed $36.4M raised across 1 round.
- Where is Triton Therapeutics, Inc. headquartered?
- Triton Therapeutics, Inc. is headquartered in Stamford, US.